胰腺导管腺癌(PDAC)是世界上最致命的癌症之一。因此,迫切需要新的治疗方案来提高PDAC患者的生存率.蛋白激酶G(PKG)进行cGMP信号的插入,这对健康和癌细胞都很重要。DT3是PKG的特异性抑制剂,并且已显示其在体外具有抗肿瘤细胞毒活性。这项工作的主要目的是研究DT3对PDAC的体内抗肿瘤作用。通过实时PCR分析在正常和肿瘤胰腺细胞中评估PKG的表达。体外细胞活力,扩散,凋亡,坏死,迁移,在DT3处理后评估鼠PDAC细胞系Panc02的侵袭。在PDAC的鼠Panc02原位模型中研究了DT3的体内抗肿瘤作用。使用蛋白质印迹分析来确定感兴趣的蛋白质的磷酸化状态。功能性PKGI优先在PDAC细胞中表达。DT3能够降低生存能力,扩散,小鼠PDAC细胞的体外迁移。同时,DT3处理没有改变小鼠肝脏的正常上皮细胞的活力。在体内,DT3治疗减少了携带PDAC的小鼠的肿瘤体积和转移,但它对延长荷瘤动物的存活是无效的。此外,DT3处理降低了鼠PDAC中GSK-3、P38和CREB的磷酸化。抑制PKG可能是PDAC治疗的潜在治疗策略,应在未来的临床前研究中仔细验证。
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in the world. Therefore, new therapeutic options are urgently needed to improve the survival of PDAC patients. Protein kinase G (PKG) conducts the interlude of cGMP signaling which is important for healthy as well as for cancer cells.
DT3 is a specific inhibitor of PKG, and it has been shown to possess an anti-tumor cytotoxic activity in vitro. The main aim of this work was to investigate anti-tumor effects of
DT3 upon PDAC in vivo.Expression of PKG was assessed with real-time PCR analysis in the normal and tumor pancreatic cells. In vitro cell viability, proliferation, apoptosis, necrosis, migration, and invasion of the murine PDAC cell line Panc02 were assessed after
DT3 treatment. In vivo anti-tumor effects of
DT3 were investigated in the murine Panc02 orthotopic model of PDAC. Western blot analysis was used to determine the phosphorylation state of the proteins of interest.Functional PKGI is preferentially expressed in PDAC cells.
DT3 was capable to reduce viability, proliferation, and migration of murine PDAC cells in vitro. At the same time, DT3 treatment did not change the viability of normal epithelial cells of murine liver. In vivo, DT3 treatment reduced the tumor volume and metastases in PDAC-bearing mice, but it was ineffective to prolong the survival of the tumor-bearing animals. In addition, DT3 treatment decreased phosphorylation of GSK-3, P38, and CREB in murine PDAC.Inhibition of PKG could be a potential therapeutic strategy for PDAC treatment which should be carefully validated in future pre-clinical studies.